(19)
(11) EP 1 551 372 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.08.2018 Bulletin 2018/31

(45) Mention of the grant of the patent:
06.06.2018 Bulletin 2018/23

(21) Application number: 03752490.7

(22) Date of filing: 22.09.2003
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61K 9/20(2006.01)
A61K 9/50(2006.01)
 A61K 9/16(2006.01)
A61K 9/28(2006.01)
(86) International application number:
PCT/US2003/029475
(87) International publication number:
WO 2004/026283 (01.04.2004 Gazette 2004/14)

(54)

SEQUESTERING SUBUNIT AND RELATED COMPOSITIONS AND METHODS

SEQUESTRIER-UNTEREINHEIT UND RELEVANTE ZUSAMMENSETZUNGEN UND VERFAHREN

SOUS-UNITE DE SEQUESTRATION ET COMPOSITIONS ET PROCEDES ASSOCIES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 20.09.2002 US 412208 P

(43) Date of publication of application:
13.07.2005 Bulletin 2005/28

(60) Divisional application:
11005554.8 / 2422772
11005555.5 / 2422773
11005556.3 / 2422775
17153385.4

(73) Proprietor: Alpharma Pharmaceuticals LLC
New York, NY 10017-5703 (US)

(72) Inventor:
  • BOEHM, Garth
    Westfield, NJ 07090 (US)

(74) Representative: Pfizer 
European Patent Department 23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)


(56) References cited: : 
WO-A-01/58447
US-A- 5 639 476
 WO-A1-01/58451
   
  • "chapter <711>: Dissolution" In: "The United States Pharmacopeia, USP 26, NF21", 1 January 2003 (2003-01-01)
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).